ASCO: Sunitinib Alone Noninferior in Metastatic Renal Cell Cancer

Sunitinib alone noninferior to nephrectomy plus sunitinib with respect to overall survival
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Nephrology, Oncology, Pharmacy, Surgery, Conference News, Source Type: news